CAMBRIDGE, Mass., Sept. 8, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that management will present a company overview and program update at two upcoming investor conferences.
